Journal of Clinical Epidemiology
Volume 52, Issue 9 , Pages 837-847 , September 1999

A Novel Form of Ascertainment Bias in Case-Control Studies of Cancer Screening

  • Timothy R. Church

      Affiliations

    • Division of Environmental and Occupational Health, University of Minnesota School of Public Health, Minneapolis, MN USA
    • Corresponding Author InformationAddress correspondence to: Timothy R. Church, University of Minnesota, School of Public Health, Division of Environmental & Occupational Health, Box 807, Mayo Memorial Building, 420 Delaware St. Southwest, Minneapolis, MN 55455

,Accepted 3 March 1999.

References 

  1. Weiss NS. Case-control studies of the efficacy of screening for cancer (Can we earn them some respect [editorial]). J Med Screen. 1997;4:57–59
  2. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980;64:1263–1272
  3. Prorok PC, Hankey BF, Bundy BN. Concepts and problems in the evaluation of screening programs. J Chronic Dis. 1981;34:159–171
  4. Morrison AS. Case definition in case-control studies of the efficacy of screening. Am J Epidemiol. 1982;115:6–8
  5. Weiss NS. Control definition in case-control studies of the efficacy of screening and diagnostic testing. Am J Epidemiol. 1983;118:457–460
  6. Sasco AJ, Day NE, Walter SD. Case-control studies for the evaluation of screening. J Chronic Dis. 1986;39:399–405
  7. Dubin N, Friedman DR, Toniolo PG, Pasternack BS. Breast cancer detection centers and case-control studies of the efficacy of screening. J Chronic Dis. 1987;40:1041–1050
  8. Frommer DJ. Case-control studies of screening [letter]. J Clin Epidemiol 1988; 41: 103–104.
  9. Sasco A. Lead time and length bias in case-control studies for the evaluation of screening. J Clin Epidemiol. 1988;41:103–104
  10. Straatman H, Verbeek AL, Peeters PH. Etiologic and prevented fraction in case-control studies of screening. J Clin Epidemiol. 1988;41:807–811
  11. Day NE. Quantitative approaches to the evaluation of screening programs. World J Surg. 1989;13:3–8
  12. Moss SM. Case-control studies of screening. Int J Epidemiol. 1991;20:1–6
  13. Knox G. Case-control studies of screening procedures. Public Health. 1991;105:55–61
  14. Connor RJ, Prorok PC, Weed DL. The case-control design and the assessment of the efficacy of cancer screening. J Clin Epidemiol. 1991;44:1215–1221
  15. Weiss NS. Case-control studies of screening (A response to George Knox). Public Health. 1992;106:127–129discussion 130
  16. Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain JO. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Community Health. 1992;46:362–364
  17. Weiss NS, McKnight B, Steven NG. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol. 1992;135:817–823
  18. Shapiro S. Goals of screening. Cancer. 1992;70(5 Suppl):1252–1258
  19. Weiss NS. Application of the case-control method in the evaluation of screening. Epidemiol Rev. 1994;16:102–108
  20. Gill TM, Horwitz RI. Evaluating the efficacy of cancer screening (Clinical distinctions and case-control studies [see comments]). J Clin Epidemiol. 1995;48:281–292
  21. Friedman GD, Hiatt RA, Quesenberry CP, Selby JV, Weiss NS. Problems in assessing screening experience in observational studies of screening efficacy (Example of urinalysis screening for bladder cancer). J Med Screening. 1995;2:219–223
  22. Hosek RS, Flanders WD, Sasco AJ. Bias in case-control studies of screening effectiveness. Am J Epidemiol. 1996;143:193–201
  23. Weiss NS, Lazovich D. Case-control studies of screening efficacy (The use of persons newly diagnosed with cancer who later sustain an unfavorable outcome). Am J Epidemiology. 1996;143:319–322
  24. Weiss N. Analysis of case-control studies of the efficacy of screening for cancer (How should we deal with tests done in persons with symptoms?). Am J Epidemiol. 1998;147:1099–1102
  25. Cronin KA, Weed DL, Connor RJ, Prorok PC. Case-control studies of cancer screening (Theory and practice). J Natl Cancer Inst. 1998;90:498–504
  26. Shapiro S, Strax P, Venet L. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA. 1966;195:731–738
  27. Zelen M. Problems in the early detection of disease and the finding of faults. Bull Intern Stat Inst. 1971;38:649–661
  28. Shapiro S, Goldberg JD, Hutchison GB. Lead time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol. 1974;100:357–366
  29. Prorok PC, Connor RJ, Baker SG. Statistical considerations in cancer screening programs. Urol Clin North Am. 1990;17:699–708
  30. Collette HJ, Day NE, Rombach JJ, de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet. 1984;1:1224–1226
  31. van der Graaf Y, Zielhuis Ga Peer PG, Vooijs PG. The effectiveness of cervical screening (A population-based case-control study). J Clin Epidemiol. 1988;41:21–26
  32. Sobue T, Suzuki T, Fujimoto I, Yokoi N, Naruke T. Population-based case-control study on cancer screening. Environ Health Perspect. 1990;87:57–62
  33. Friedman DR, Dubin N. Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol. 1991;133:974–984
  34. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer [see comments]. N Engl J Med. 1992;326:653–657
  35. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study [see comments]. Ann Intern Med. 1993;118:1–6
  36. Lazovich D, Weiss NS, Stevens NG, White E, McKnight B, Wagner EH. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen. 1995;2:84–89
  37. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans [see comments]. Ann Intern Med. 1995;123:904–910
  38. Herrinton LJ, Selby JV, Friedman GD, Quesenberry CP, Weiss NS. case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol. 1995;142:961–964
  39. Rothman KJ, Greenland S. Modern Epidemiology. 2nd Edition. Philadelphia: Lippincott-Raven; 1998;
  40. Prorok PC. The theory of periodic screening I (Lead time and proportion detected). Adv Appl Prob. 1976;8:127–143
  41. Ries LAG, Kosary CL, Hankey BF, Harras A, Miller BA, Edwards BK. SEER Cancer Statistics Review, 1973–1993 (Tables and Graphs). Bethesda, MD: National Cancer Institute; 1996;
  42. Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy [see comments]. Lancet. 1993;341:736–740
  43. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality [see comments]. J Natl Cancer Inst. 1992;84:1572–1575
  44. Richert-Boe K, Humphrey L, Glass A, Weiss N. Screening digital rectal examination and prostate cancer mortality (a case-control study). J Med Screening. 1998;5:99–103
  45. Selby J, Friedman G, Quesenberry CJ. Case-control evaluation of screening. [letter]. J Clin Epidemiol. 1996;49:390–391
  46. Selby JV, Friedman GD, Newcomb PA, Weiss NS. Case-control studies of colorectal cancer mortality (Is the case made for screening sigmoidoscopy? [letter]). J Natl Cancer Inst. 1993;85:503–505

PII: S0895-4356(99)00073-6

Journal of Clinical Epidemiology
Volume 52, Issue 9 , Pages 837-847 , September 1999

Article Tools

* Image Usage & Resolution